CHAN MITCHELL (Chief Financial Officer) received a stock award from REGENXBIO INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/18/2024ACC: 0001562180-24-006869
Officer· Chief Financial Officer
Since Sep 2024
+348.23K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
348.23K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+58.87K
Price / share
—
Trade value
—
% of position
New position
9/16/2024
0.00→58.87K
Total
Net shares
+58.87K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2024 | A · Award | +58.87K | — | — | New position | 0.00 | 58.87K |
| Total | +58.87K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
289.36K shares
Shares
+289.36K
Strike price
12.74
Held after
289.36K
Exercisable
—
9/16/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock289.36K shares | 9/16/2024 | A · Award | +289.36K | 12.74 | — | 289.36K |